Polylite Taiwan Co Ltd
Polylite Taiwan's capital structure shows a debt-to-equity ratio of 0.32, indicating a relatively conservative leverage position compared to industry norms. However, the company's liquidity is rated as medium, with a current ratio of 1.13, suggesting limited short-term liquidity cushion. The company's cash and equivalents amount to TWD 106,032,000, but this is offset by long-term debt of TWD 217,528,000, resulting in a net cash position that is negative after subtracting total debt. Profitability metrics are weak, with a return on equity (ROE) of -7% and a return on assets (ROA) of -5.14%. These figures indicate that the company is not generating returns for shareholders or effectively utilizing its assets. The operating cash flow of TWD 46,809,000 is positive, but the free cash flow is negative at TWD -13,314,000, reflecting capital expenditure outflows of TWD -10,275,000. These metrics fall below the industry median for medical equipment firms, which typically exhibit positive ROE and ROA. The company's revenue is concentrated in the domestic market and overseas markets, with no disclosed segment breakdown. This lack of segment data limits visibility into geographic exposure and product-specific performance. The absence of detailed revenue concentration data makes it difficult to assess the risk of overreliance on any single market or product line. Growth trajectory is uncertain, with no forward-looking revenue guidance provided in the input data. Historical financials show a revenue of TWD 304,320,000, but the company reported a net loss of TWD -47,935,000. The lack of positive earnings and the negative gross profit of TWD -52,322,000 suggest operational challenges. Without clear evidence of margin improvement or cost control, the company's ability to sustain or grow revenue is questionable. Risk factors include medium liquidity risk and a negative net cash position after debt. The company's dilution risk is rated as low, with no near-term pressure from share issuance or convertible instruments. However, the negative net income and operating income raise concerns about the company's ability to service debt and maintain operations without external financing. Recent events include the latest financial filing (HA-latest), which discloses the company's current financial position. No recent earnings call transcripts or material events are included in the input data, limiting insight into management's strategic direction or operational updates.
Business. Polylite Taiwan Co., Ltd. is a Taiwan-based company engaged in the research, development, manufacture, and distribution of optical lenses, including vision correction, polarized, and anti-blue lenses, primarily for the healthcare sector.
Classification. Polylite Taiwan is classified under the industry "Medical Equipment, Supplies & Distribution" within the Healthcare Services & Equipment business sector, with a confidence level of 0.92.
- Polylite Taiwan is operating at a loss with negative returns on equity and assets.
- The company's liquidity is constrained, with a current ratio of 1.13 and a negative net cash position after debt.
- Revenue concentration data is not disclosed, limiting visibility into geographic and product-specific risks.
- Growth prospects are unclear due to the absence of forward-looking guidance and negative operating performance.
- Dilution risk is low, but the company may require external financing to sustain operations.
- --
- ## RATIONALES
- ```json
- Net cash is negative after subtracting total debt.